Published in Infect Immun on July 01, 1983
Human microsporidial infections. Clin Microbiol Rev (1994) 4.66
Microsporidia and human infections. Clin Microbiol Rev (1989) 1.66
Immune response to Encephalitozoon cuniculi infection. Microbes Infect (2001) 1.03
Trichinella pseudospiralis larvae express natural killer (NK) cell-associated asialo-GM1 antigen and stimulate pulmonary NK activity. Infect Immun (1988) 0.83
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
Natural killer cells: their roles in defenses against disease. Science (1981) 4.59
Interleukin-2 augments natural killer cell activity. Nature (1981) 4.15
Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature (1978) 3.72
An analysis of the murine NK cell as to structure, function and biological relevance. Immunol Rev (1979) 3.15
Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance. Nat New Biol (1972) 2.44
On the heterogeneity of murine natural killer cells. J Exp Med (1981) 2.15
The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function. J Immunol (1979) 2.11
Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells. J Immunol (1978) 2.04
The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol (1979) 2.02
Identification of a cell-surface antigen selectively expressed on the natural killer cell. J Exp Med (1977) 1.97
Encephalitozoonosis (nosematosis) and toxoplasmosis. Am J Pathol (1971) 1.70
Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells. J Immunol (1980) 1.68
The role of activated macrophages in specific and nonspecific cytostasis of tumor cells. J Immunol (1974) 1.56
Fc receptors on mouse effector cells mediating natural cytotoxicity against tumor cells. J Immunol (1977) 1.53
Generation of natural killer cells: an autonomous function of the bone marrow. J Exp Med (1977) 1.19
Increased natural killer cell activity in experimental American trypanosomiasis. J Immunol (1981) 1.17
Nosema cuiculi: in vitro isolation. Science (1969) 1.17
Some factors influencing the in vitro infectivity and replication of Encephalitozoon cuniculi. J Protozool (1978) 1.08
Augmented followed by suppressed levels of natural cell-mediated cytotoxicity in mice infected with Toxoplasma gondii. Infect Immun (1982) 1.04
Susceptibility of selected inbred strains of mice to Encephalitozoon cuniculi. J Infect Dis (1981) 1.04
Natural killer cells and their possible relevance to transplantation biology. Transplantation (1982) 0.98
Detection of latent murine nosematosis and growth of Nosema cuniculi in cell cultures. Can J Microbiol (1970) 0.96
Altered immune responsiveness associated with Encephalitozoon cuniculi infection in rabbits. Infect Immun (1977) 0.94
Studies on a murine ascites-producing agent and its effect on tumor development. Cancer Res (1966) 0.87
Spontaneous Nosema cuniculi infection in laboratory rabbits. J Am Vet Med Assoc (1969) 0.84
In vivo generation of mouse natural killer cells: role of the spleen and thymus. Scand J Immunol (1978) 0.82
Renal nosematosis in young rabbits. Pathol Vet (1970) 0.78
Virus resistance in rabbit kidney cell cultures contaminated by a protozoan resembling Encephalitozoon cuniculi. Proc Soc Exp Biol Med (1973) 0.77
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A (1991) 4.85
IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol (2009) 2.65
Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim Biophys Acta (1980) 1.66
Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med (1981) 1.63
Cellular electrophoretic mobility and the mitotic cycle. J Gen Physiol (1966) 1.51
Oral immunisation as a strategy for enhancing corneal allograft survival. Br J Ophthalmol (1997) 1.51
Spontaneous corneal neovascularization in nude mice. Local imbalance between angiogenic and anti-angiogenic factors. Invest Ophthalmol Vis Sci (1993) 1.41
Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol (1998) 1.40
Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions. J Parasitol (2002) 1.40
Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells. J Immunol (1985) 1.38
Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res (1992) 1.38
Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci (1991) 1.34
Incorporation of lipid vesicles by mammalian cells provides a potential method for modifying cell behaviour. Nature (1974) 1.33
A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol (1998) 1.30
The effect of neuraminidase on the phagocytic process in human monocytes. Lab Invest (1966) 1.27
Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology (1998) 1.23
Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci (2001) 1.21
Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens. J Exp Med (1980) 1.21
In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii. Invest Ophthalmol Vis Sci (1990) 1.21
Different fates of Legionella pneumophila pmi and mil mutants within macrophages and alveolar epithelial cells. Microb Pathog (1998) 1.20
Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus. Invest Ophthalmol Vis Sci (1984) 1.19
Role of antibody and complement in the control of Encephalitozoon cuniculi infections by rabbit macrophages. Infect Immun (1980) 1.19
In vitro and in vivo tumoricidal properties of a pathogenic/free-living amoeba. Cancer Lett (1993) 1.19
Mannose induces the release of cytopathic factors from Acanthamoeba castellanii. Infect Immun (1998) 1.17
Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes. Cancer (1993) 1.16
Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles. Cancer Res (1976) 1.12
Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes. Int J Cancer (1992) 1.11
Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J Immunol (2001) 1.10
Metastatic inefficiency in mice bearing B16 melanomas. Br J Cancer (1982) 1.09
The role of macrophages in Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (1996) 1.08
Increased ouabain-sensitive 86Rb+ uptake and sodium and potassium ion-activated adenosine triphosphatase activity in transformed cell lines. J Biol Chem (1975) 1.08
Cellular uptake of cyclic AMP captured within phospholipid vesicles and effect on cell-growth behaviour. Biochim Biophys Acta (1974) 1.08
Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes. Eur J Cancer Clin Oncol (1982) 1.08
Quantitation of tumorigenic disseminating and arrested cancer cells. Br J Cancer (1984) 1.07
Antigenic cross-reactivity among different microsporidan spores as determined by immunofluorescence. J Parasitol (1980) 1.06
Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci (1995) 1.05
Allergic airway hyperreactivity increases the risk for corneal allograft rejection. Am J Transplant (2009) 1.04
Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer (1997) 1.04
Susceptibility of selected inbred strains of mice to Encephalitozoon cuniculi. J Infect Dis (1981) 1.04
The role of contact lenses, trauma, and Langerhans cells in a Chinese hamster model of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (1993) 1.04
Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J Immunol (2000) 1.03
Characterization and pathogenic potential of a soil isolate and an ocular isolate of Acanthamoeba castellanii in relation to Acanthamoeba keratitis. Curr Eye Res (1992) 1.03
The effect of polycations on cell membrane stability and transport processes. J Membr Biol (1973) 1.03
Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors. J Immunol (1987) 1.03
Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. J Immunol (1983) 1.02
Apoptosis as a mechanism of cytolysis of tumor cells by a pathogenic free-living amoeba. Infect Immun (1994) 1.02
Cellular uptake and protection against virus infection by polyinosinic-polycytidylic acid entrapped within phospholipid vesicles. Mol Pharmacol (1977) 1.02
Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. Cancer Res (1993) 1.00
The Legionella pneumophila hel locus encodes intracellularly induced homologs of heavy-metal ion transporters of Alcaligenes spp. Infect Immun (1996) 1.00
Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes. Int J Cancer (1993) 0.99
Ribonuclease-susceptible charged groups at the surface of Ehrlich ascites tumour cells. Int J Cancer (1969) 0.99
Intracameral inoculation of herpes simplex virus type I induces anterior chamber associated immune deviation. Curr Eye Res (1983) 0.99
Analysis of antibody production induced by allogeneic tumor cells inoculated into the anterior chamber of the eye. Transplantation (1982) 0.99
Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J Immunol (2001) 0.98
The effect of oral immunization on corneal allograft survival. Transplantation (1996) 0.97
Acanthamoeba keratitis. CLAO J (1995) 0.96
Hydrolyzable hydrophobic taxanes: synthesis and anti-cancer activities. Anticancer Drugs (2001) 0.96
Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea (2001) 0.96
Cellular binding of 3H-cytochalasin B. J Cell Physiol (1974) 0.96
The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest Ophthalmol Vis Sci (2000) 0.95
Characterization of a plasminogen activator produced by Acanthamoeba castellanii. Mol Biochem Parasitol (1995) 0.95
Role of splenic B cells in the immune privilege of the anterior chamber of the eye. Eur J Immunol (1995) 0.95
The diagnosis and management of Acanthamoeba keratitis. CLAO J (2000) 0.94
Selective therapy of metastasis. I. Quantitation of tumorigenic circulating and covert cancer cells disseminated from metastatic and nonmetastatic tumors. Cancer Drug Deliv (1984) 0.94
Autoimmunity at the ocular surface: pathogenesis and regulation. Mucosal Immunol (2010) 0.93
Targeted drug delivery. Cancer (1986) 0.93
A pig model of Acanthamoeba keratitis: transmission via contaminated contact lenses. Invest Ophthalmol Vis Sci (1992) 0.93
Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size. Drug Metab Dispos (1979) 0.93
Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol (1996) 0.93
Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes. Cancer Treat Rep (1980) 0.93
Interactions of La2+ with phosphatidylserine vesicles: binding, phase transition, leakage, 31P-NMR and fusion. Biochim Biophys Acta (1981) 0.93
Role of mucosal IgA in the resistance to Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (1998) 0.93
Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology (1996) 0.93
Systemic immune response to Acanthamoeba keratitis in the Chinese hamster. Ocul Immunol Inflamm (1997) 0.92
Novel Taxol formulations: Taxol-containing liposomes. J Natl Cancer Inst Monogr (1993) 0.92
In vitro characterization of Acanthamoeba castellanii cytopathic effect. J Parasitol (1995) 0.91
Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis. Immunology (1995) 0.90
Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate. Invest Ophthalmol Vis Sci (1999) 0.90
Pharmacokinetics and anti-tumor activity of vincristine encapsulated in sterically stabilized liposomes. Int J Cancer (1995) 0.90
On the intracellular uptake of neuraminidase. Exp Cell Res (1967) 0.90
IFN-γ blocks CD4+CD25+ Tregs and abolishes immune privilege of minor histocompatibility mismatched corneal allografts. Am J Transplant (2013) 0.90
Pulmonary alveolar macrophage function during acute inflammatory lung injury. Am Rev Respir Dis (1987) 0.90
Immunologic evaluation of spontaneous regression of an intraocular murine melanoma. Invest Ophthalmol Vis Sci (1990) 0.90
Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Invest Ophthalmol Vis Sci (1997) 0.89
Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes. Cancer Res (1993) 0.89
Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases. Arch Ophthalmol (2001) 0.89
Expression of HLA class I and II antigens on cells of the human trabecular meshwork. Ophthalmology (1987) 0.89
Cytochalasin B and the sialic acids of Ehrlich ascites cells. Exp Cell Res (1974) 0.89
Spontaneous immune rejection of intraocular tumors in mice. Invest Ophthalmol Vis Sci (1985) 0.89
Robonucelic acid within the cellular peripheral zone and the binding of calcium to ionogenic sites. J Cell Physiol (1967) 0.89
Reversibility of ouabain induced inhibition of cell division and cation transport in Ehrlich ascites cells. J Cell Physiol (1968) 0.88
Reversible depression of the reticuloendothelial system by liposomes. Biochim Biophys Acta (1982) 0.88
Electrophoretic mobilities of tissue culture cells in exponential and parasynchronous growth. Nature (1965) 0.88